发明名称 |
Crystalline solid and amorphous forms of (-)-halofenate and methods related thereto |
摘要 |
The present invention provides crystalline solid and amorphous forms of (-)-halofenate. The crystalline solid forms may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of conditions associated with blood lipid deposition in a mammal, particularly those diseases related to Type 2 diabetes and hyperlipidemia. The invention also relates to a method for preventing or treating Type 2 diabetes and hyperlipidemia in a mammal comprising the step of administering a therapeutically effective amount of crystalline solid and amorphous forms of (-)-halofenate.
|
申请公布号 |
US8507719(B2) |
申请公布日期 |
2013.08.13 |
申请号 |
US201213470142 |
申请日期 |
2012.05.11 |
申请人 |
DAUGS EDWARD D.;HAGEN ERIC J.;HANKO JASON A.;LOUKS DAVID H.;METABOLEX, INC.;DIATEX, INC. |
发明人 |
DAUGS EDWARD D.;HAGEN ERIC J.;HANKO JASON A.;LOUKS DAVID H. |
分类号 |
C07C67/02 |
主分类号 |
C07C67/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|